T 2851/18 (Lixisenatide for treating obese type 2 diabetics/SANOFI) of 17.12.2020
- European Case Law Identifier
- ECLI:EP:BA:2020:T285118.20201217
- Date of decision
- 17 December 2020
- Case number
- T 2851/18
- Petition for review of
- -
- Application number
- 10747854.7
- IPC class
- A61K 38/22A61K 38/26A61P 3/10
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Use of AVE0010 for the manufacture of a medicament for the treatment of Diabetes mellitus Type 2
- Applicant name
- Sanofi-Aventis Deutschland GmbH
- Opponent name
- Generics (U.K.) Limited
- Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 113(2) (2007)
- Keywords
- Basis of decision - agreement to text of the patent as granted withdrawn by patent proprietor
Basis of decision - patent revoked - Catchword
- -
- Cited cases
- T 0073/84
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The patent is revoked.